Literature DB >> 22450686

Not being able to see the muscle for the fat.

Christopher J Oliver1.   

Abstract

Entities:  

Year:  2012        PMID: 22450686      PMCID: PMC3302988          DOI: 10.1007/s13539-012-0058-6

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


× No keyword cloud information.
At its simplest, we can express body weight or body composition as comprising of adipose tissue, muscle tissue and skeletal tissue. Body weight and body mass index (BMI) of populations of all ages have been increasing for close to half a century, leading to the present obesity epidemic. The causal pathways linking excessive body fat to serious chronic diseases, including diabetes and heart diseases is now well established. A recent editorial citing body composition data from Li et al. [1] asked the question “Are Normal-Weight Americans Over-Fat?” [2]. This interpretation of the data from Li et al. reinforces an adipocentric view giving adipose tissue primacy; perhaps there is a different view, a sarcocentric view that proposes that people are perhaps becoming under-muscled rather than just over-fat. Data from Canada [3] and Germany [4] indicate that children and adults are getting fatter at the same body weight or BMI. If we are fatter at the same body weight and BMI then the other two tissues, muscle and or bone must be diminishing. Given that this increased body fatness at the same weight is most likely a proxy for decreased physical activity, it is a good bet that muscle is the tissue that has diminished most. The loss of muscle is of great physiological importance as proper-functioning muscle is responsible for most glucose disposal and required to stave off insulin resistance [5, 6]. Proper functioning muscle has been highlighted as important for longevity even after accounting for respiratory fitness and BMI [7]. Therefore it is important to remind those with an adipocentric perspective that a low body fat in itself is not necessarily healthy if it coexists with poor-quality muscle and bone. This is important given various body composition states such as metabolically normal obese individuals [8] and thin persons with significant ectopic fat [9]. We may have better health outcomes if we focus more on the causes and sequelae of body dyscomposition, especially the diminution of muscle mass and function even in the young, rather than assuming the problems of body composition in the general population largely lie in terms of adiposity. The retention and maintenance of muscle and muscle function is coming under increasing scrutiny in our ageing society because of the looming epidemic of sarcopenia and the financial and social impact that this will have. However, the discussion around the diagnosis and prevalence on sarcopenia is centred on the target clinical population, i.e., the elderly [10]. Nevertheless, the data cited above from the USA, Canada and Germany studies highlight that on current form, a number of our children may not meet their genetic potential of muscle mass and by inference muscle function. The medium-term consequences of this muscle shortfall as a risk factor for type 2 diabetes alone is of concern; the longer-term consequences of any muscle shortfall to sarcopenia prevalence and its possible inception at a younger age should be of even greater concern. Those concerned with sarcopenia, including this journal, perhaps need also to focus more on prevention even starting with childhood.
  10 in total

Review 1.  Characterizing the profile of obese patients who are metabolically healthy.

Authors:  V Primeau; L Coderre; A D Karelis; M Brochu; M-E Lavoie; V Messier; R Sladek; R Rabasa-Lhoret
Journal:  Int J Obes (Lond)       Date:  2010-10-26       Impact factor: 5.095

2.  Are normal-weight Americans over-fat?

Authors:  Marie-Pierre St-Onge
Journal:  Obesity (Silver Spring)       Date:  2010-11       Impact factor: 5.002

3.  Inverse associations between muscle mass, strength, and the metabolic syndrome.

Authors:  Evan Atlantis; Sean A Martin; Matthew T Haren; Anne W Taylor; Gary A Wittert
Journal:  Metabolism       Date:  2009-07       Impact factor: 8.694

4.  Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey.

Authors:  Preethi Srikanthan; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2011-07-21       Impact factor: 5.958

5.  An overview of sarcopenia: facts and numbers on prevalence and clinical impact.

Authors:  Stephan von Haehling; John E Morley; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

6.  Secular changes of anthropometric measures for the past 30 years in South-West Germany.

Authors:  G Nagel; M Wabitsch; C Galm; S Berg; S Brandstetter; M Fritz; J Klenk; R Peter; D Prokopchuk; R Steiner; S Stroth; O Wartha; S K Weiland; J Steinacker
Journal:  Eur J Clin Nutr       Date:  2009-08-19       Impact factor: 4.016

7.  Estimates of body composition with dual-energy X-ray absorptiometry in adults.

Authors:  Chaoyang Li; Earl S Ford; Guixiang Zhao; Lina S Balluz; Wayne H Giles
Journal:  Am J Clin Nutr       Date:  2009-10-07       Impact factor: 7.045

8.  The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat.

Authors:  E Louise Thomas; James R Parkinson; Gary S Frost; Anthony P Goldstone; Caroline J Doré; John P McCarthy; Adam L Collins; Julie A Fitzpatrick; Giuliana Durighel; Simon D Taylor-Robinson; Jimmy D Bell
Journal:  Obesity (Silver Spring)       Date:  2011-06-09       Impact factor: 5.002

9.  Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.

Authors:  Stephan von Haehling; John E Morley; Andrew J S Coats; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-10-26       Impact factor: 12.910

10.  Association between muscular strength and mortality in men: prospective cohort study.

Authors:  Jonatan R Ruiz; Xuemei Sui; Felipe Lobelo; James R Morrow; Allen W Jackson; Michael Sjöström; Steven N Blair
Journal:  BMJ       Date:  2008-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.